Application of emollients is a widespread traditional newborn care practice in many low and middle-income countries (LMICs) and may have the potential to decrease infection and consequent mortality in preterm neonates.
Rhesus (Rh) disease and extreme hyperbilirubinemia (EHB) result in neonatal mortality and long-term neurodevelopmental impairment, yet there are no estimates of their burden.
Data are lacking for impairment after neonatal sepsis and pneumonia, especially among those of >32 wk gestation.
Neonatal encephalopathy (NE) following an intrapartum hypoxic event is a strong predictor of long-term impairment.
Retinopathy of prematurity (ROP) is a leading cause of potentially avoidable childhood blindness worldwide. We estimated ROP burden at the global and regional levels to inform screening and treatment programs, research, and data priorities.
In 2010, there were an estimated 15 million preterm births worldwide (<37 wk gestation). Survivors are at risk of adverse outcomes, and burden estimation at global and regional levels is critical for priority setting.
Neonatal mortality and morbidity are increasingly recognized as important globally, but detailed estimates of neonatal morbidity from conditions and long-term consequences are yet to be published.
This series gives the first systematic estimates of impairment after the major neonatal conditions notably preterm birth, neonatal infections, Intrapartum conditions/neonatal encephalopathy, hyperbilirubinaemia/Rhesus disease, and Retinopathy of prematurity.